Recently, a core product, medicinal corn starch, has continued to provide support for the pharmaceutical formulation field with standardized production standards and stable supply capacity. This product has formed a mature system in terms of quality control and service guarantee, always adhering to the business principle of "reasonable price, reputation first", and providing reliable auxiliary material selection for downstream customers.
It is understood that this medicinal corn starch is derived from the grain of the cereal plant, maize, and is in the form of a white or off white powder. It is insoluble in water and ethanol and meets the relevant standards of the Chinese Pharmacopoeia 2020 edition, matching the characteristics requirements of medicinal excipients. In terms of key quality indicators, the microbial limit control of this product is strict, providing a basic safety guarantee for downstream formulation production.
In terms of medicinal functions, this corn starch mainly serves as a filler and disintegrant, and is widely used in the production of solid pharmaceutical preparations such as tablets, granules, and capsules. Its water absorption and expansion characteristics can help the formulation form a stable structure, while also playing a role in regulating the volume of the formulation and ensuring dose uniformity during the production process. Targeting different scenario requirements.
Relying on the flexible supply model of "one bottle, one piece minimum order" and a comprehensive qualification system, this medicinal corn starch has been continuously serving various customers such as hospital preparation rooms, laboratories, and pharmaceutical companies. The relevant person in charge stated that they will always take pharmacopoeia standards as the core, and ensure the stability and compliance of the pharmaceutical excipient supply chain through standardized quality control and pragmatic service response.
